ask="43.49"
ask_size="200"
average_daily_volume="1095240"
bid="37.50"
bid_size="100"
book_value="3.62"
change="-0.15"
change_from_200_day_moving_average="-2.16"
change_from_50_day_moving_average="0.89"
change_from_52_week_high="-11.66"
change_From_52_week_low="11.31"
change_in_percent="-0.34%"
close="43.49"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.63"
ebitda="-145.92M"
eps_estimate_current_year="-2.34"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-1.30"
ex_dividend_date="N/A"
float_shares="85906000"
high="43.95"
high_52_weeks="55.15"
last_trade_date="3/7/2017"
last_trade_price="43.49"
last_trade_size="54790"
last_trade_time="4:00pm"
low="42.62"
low_52_weeks="32.18"
market_capitalization="3.79B"
moving_average_200_day="45.65"
moving_average_50_day="42.60"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="67.67"
open="43.17"
pe_ratio="N/A"
peg_ratio="0.51"
percent_change_from_200_day_moving_average="-4.73%"
percent_change_from_50_day_moving_average="+2.10%"
percent_change_from_52_week_high="-21.14%"
percent_change_from_52_week_low="+35.15%"
previous_close="43.64"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="12.04"
price_per_sales="253.44"
revenue="15.00M"
shares_outstanding="87114000"
short_ratio="3.47"
stock_exchange="NMS"
symbol="NBIX"
volume="497293"
weeks_range_52="32.18 - 55.15"
